Voices of Biotech
Podcast: MilliporeSigma says education vital to creating unbreakable chain for sustainability
MilliporeSigma discusses the importance of people, education, and the benefits of embracing discomfort to bolster sustainability efforts.
2 Min Read
Kemwell Biopharma is a single-source service provider supporting early product development to commercial supplies of biopharmaceutical products.
Founded in 1980, Kemwell is a 100% customer-oriented company with expertise in contract development and manufacturing services for pharmaceutical and biopharmaceutical products. Throughout its journey, Kemwell has maintained its pure-play status as a 100% contract services provider. Their core values and work culture being: “Customer Comes First. Always.” Kemwell has been successfully serving Big Pharma customers, including AstraZeneca, Bayer, GSK, Merck, Novartis, Pfizer, and many small and mid-pharma companies from its FDA and EMA certified facilities in India and Sweden.
Kemwell now extends its reach to allow the biotechnology industry to take better advantage of the eastern promise of cost savings combined with the support and technology of the west. To offer these services, Kemwell has built a new 135,000- ft2 biopharmaceutical development and manufacturing facility in Bangalore, India. It was designed in collaboration with Boehringer Ingelheim under a strategic alliance. This facility offers services ranging from full-service process development, manufacture, formulation and fill and finish.
Development Services
Process development
Formulation development
Analytical development and validation
Pre-clinical manufacturing
GMP Manufacturing Services
Drug substance (80-L, 400-L, and 2 × 2,000-L stainless steel)
Clinical and commercial manufacturing
Drug product
Vials
Lyophilization
Pre-filled syringes
Support services
Analytical and stability testing
cGMP cell banking and storage
Regulatory submission support
Why Kemwell?
Since this expansion into the biologics space builds on the sterling service Kemwell already provides to the pharmaceutical sector, the company can draw on its over 30-year experience of customer service and knowledge of global compliance requirements, including FDA and EMA requirements. The company boasts a deep understanding of customers’ requirements and prides itself on excellent quality service. These same values will be extended into the biotech services assuring affordable prices.
About the Author
Author Details
Christian Ahlmark (1-919-397-3000, [email protected]) and Bhaskar Viswanathan (91-96864-46433, [email protected]) are in business development at Kemwell Biopharma Pvt. Ltd., India, USA, and Sweden; www.kemwellbiopharma.com.
You May Also Like
Upcoming Webcasts
Jun 17 - Jun 20, 2024
Jun 17 - Jun 20, 2024
Our Biopharmaceutical School is the perfect course to gain a well-rounded understanding of the Biopharmaceutical industry. Over three days, you will understand the principle steps in the biopharmaceutical lifecycle, including: raw material selection, up and downstream processes and core technology. Additionally, you will be familiarised with the latest industry trends, including Industry 4.0, and how these are likely to impact the industry’s evolution.
Through a combination of sessions led by experts from the likes of GSK and Pall Biotech, as well as group discussions with your peers, you will learn how to bring a biopharmaceutical drug to market. Each day will be chaired by a different member of the BioProcess International Academy faculty and there will also be time for networking and Q&As with the experts.
Learn More